- CTMX -8.59%
Shareholders in CytomX Therapeutics (NASDAQ:CTMX) are in the red if they invested five years ago
Yahoo Finance · 7 days ago
Open | 1.6100 |
High | 1.6250 |
Low | 1.4750 |
Mkt Cap | 116.1M |
P/E (TTM) | 7.10 |
Div & Yield | N/A & N/A |
Prev. Close | 1.6300 |
52 Wk. Low | 1.0400 |
52 Wk. High | 5.8500 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 41.46M | 76.40% ▲ |
Net Income | 13.79M | - |
Diluted EPS | 0.17 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.14 | - |
Q1 2024 | -$0.08 | $0.17 |
Q4 2023 | -$0.03 | $0.01 |
S&P FuturesES=F | 5,387.00+3.00 (+0.06%) |
Dow FuturesYM=F | 38,795.00+1.00 (+0.00%) |
Nasdaq FuturesNQ=F | 19,265.00+22.75 (+0.12%) |
123.88-0.50% | |
Apple Inc.AAPL | 207.15+7.26% |
33.80+11.04% |